Ibrance 125mg 25’s Tablets (Palbocicib)

Product Description

Brand: Ibrance
Packet Size: 25 tablets
Active ingredient: Palbocicib
Manufacturer: Pfizer
Treatment: Breast Cancer

Uses of the Ibrance 125mg Tablets

Ibrance (palbociclib) is a medication used to treat a specific type of advanced breast cancer in adults. It’s specifically designed to treat:

HR-positive (hormone receptor-positive) breast cancer: This means the cancer’s growth is stimulated by hormones like estrogen or progesterone.

HER2-negative breast cancer: This means the cancer cells don’t have abnormally high levels of a protein called HER2.

How Does Ibrance 125mg Tablet Work?

Ibrance (palbociclib) is a targeted therapy, meaning it specifically targets cancer cells without harming healthy cells. It works by:

Blocking CDK4 and CDK6 enzymes: These enzymes are proteins involved in cell growth and division. By blocking them, Ibrance slows down the growth and spread of cancer cells.

Essentially, Ibrance acts as a brake on cancer cell growth, giving the body a better chance to fight the disease.

How Should You Take Ibrance 125mg Tablet?

Ibrance 125mg tablets are typically taken in a specific cycle:

3 weeks on: You take one tablet daily for 21 days.
1 week off: You do not take Ibrance for 7 days.

Swallow the tablet whole: Do not chew, crush, or split it.
Timing: While you can take it with or without food, it’s best to take it at the same time each day for consistency.
Avoid grapefruit: Grapefruit can interact with Ibrance, so it’s best to avoid it.